CSS
PRPH

Cubist Systematic Strategies’s ProPhase Labs PRPH Stock Holding History

Cubist Systematic Strategies’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,177
Closed -$4.6K – 3438
2025
Q2 		$4.6K Buy
+1,177
New +$3.94K ﹤0.01% 2855
2022
Q4 		– Sell
-1,654
Closed -$187K – 4526
2022
Q3 		$187K Buy
1,654
+121
+8% +$14.1K ﹤0.01% 3803
2022
Q2 		$194K Buy
+1,533
New +$135K ﹤0.01% 3724

Other funds holding PRPH

SC
Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cubist Systematic Strategies's PRPH Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of ProPhase Labs (PRPH) in Q3 2025, closing a stake of 1,177 shares — an estimated $4.6K sold.

Cubist Systematic Strategies first reported a position in PRPH in Q2 2022 and held it in 3 quarters. The position peaked at $194K in Q2 2022. 28 funds tracked by Wall St. Rank hold PRPH as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining ProPhase Labs position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,177 ProPhase Labs shares in Q3 2025, an estimated $4.6K.
  • Cubist Systematic Strategies first reported a position in ProPhase Labs in Q2 2022 and held it in 3 quarters.
  • Cubist Systematic Strategies's ProPhase Labs position peaked at $194K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.